 |
Quick Links |
| Information by Disease |
|
|
|
| Cancer News |
|
|
|
| Conference Coverage |
|
|
|
| AZN | $44.82 | -0.37 (-0.82%)
| | NVS | $53.13 | -0.16 (-0.3%)
| | SNY | $37.67 | -0.01 (-0.03%)
| | GSK | $41.53 | 0.06 (0.14%)
|
|
|
Sarcoma
| Panretin (alitretinoin) |
Retinoic acid |
Ligand |
II |
| Proact |
Immunomodulator |
IDM Biotech |
III |
| SC4071 |
|
Primecyte, Signature Bioscience |
II |
| Taxotere (docetaxel) |
Taxoid |
Aventis |
II |
| Yondelis (ecteinascidin) |
Cytotoxic Tetrahydroisoquinoline alkaloid |
Ortho Biotech |
III |
|
For more information contact us at clinicaltrials@cancerconsultants.com
 |
 View Drugs in Pipeline By Disease |
 |
|
|
|
 |
|
 |
|
|
Patient Home
Meeting Calendar
